A team of scientists from Wake Forest University School of Medicine and the University of Southern California (USC) have demonstrated the first successful use of a neural prosthetic device to recall specific memories.

Abbott (NYSE: ABT)+
announced today that an FDA advisory committee ruled that the benefits of its TriClip outweigh the risks in treating tricuspid regurgitation (TR).

Three Medicare Administrative Contractors will start covering the Eversense E3 CGM for people who only take basal insulin.